FDA approves ZetrOZ’s sam 2.0 wearable unit for additional medical uses
The technology, documented in more than 40 studies, has been used by athletes for sports injury treatment.
10 January 2024
10 January 2024
The technology, documented in more than 40 studies, has been used by athletes for sports injury treatment.
NVIDIA announced new advances to the healthcare industry at the J P Morgan Healthcare Conference, including its partnership with Amgen.
The non-invasive tool is launched in the US with the Clarius PAL HD3, Clarius PA HD3, and Clarius C3 HD3 models.
The OptiView transparent dressing with HydroCore Technology is designed for skin monitoring and pressure injury prevention.
The new software update on the Swoop system features the diffusion-weighted imaging artificial intelligence (AI) denoising tool, which is approved by the US Food and Drug Administration (FDA).
The trial assessing the scanner’s ability to differentiate between cancerous and benign lesions will run until December 2024.
Supported by a £300,000 donation, the trial is set to enrol hospital patients across the UK in hopes of using spinal cord stimulation to restore quality of life.
GlobalData predicts that the major technology themes expected to influence the medical device industry in 2024 are AI, cybersecurity, robotics, AI regulation, and digitalization. Furthermore, remote patient monitoring and precision medicine have been identified as the major industry themes set to shape the the medical devices market in 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Give your business an edge with our leading industry insights.